Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Certified by Founder
Lodge
XyloCor Therapeutics, Inc.
start up
United States
- King of Prussia, Pennsylvania
- 09/01/2025
- Series B
- $67,500,000
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
- Industry Research Services
- Website https://www.xylocor.com/
- LinkedIn https://www.linkedin.com/company/xylocor-therapeutics-inc./
Carbon(US) | $60,000,000 | (Nov 14, 2025)
Big Rentals | $2,800,000 | (Nov 14, 2025)
Bindwell | $6,000,000 | (Nov 14, 2025)
Anzen Insurance | $16,000,000 | (Nov 14, 2025)
Beacon Biosignals | $86,000,000 | (Nov 14, 2025)
Fabric8Labs | $50,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
sunday (US) | $21,000,000 | (Nov 14, 2025)
Maybern | $50,000,000 | (Nov 14, 2025)